Total planned funding: $238,736,571
Clear active filters
U.S. Centers for Disease Control and Prevention
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Uganda | $26,671,788 |
| Kenya | $20,095,860 |
| Ethiopia | $19,885,896 |
| Côte d'Ivoire | $18,872,386 |
| Mozambique | $18,249,647 |
| Nigeria | $17,696,213 |
| Zambia | $16,867,830 |
| Tanzania | $14,741,370 |
| Botswana | $14,347,847 |
| South Africa | $13,847,470 |
| Caribbean Region | $6,472,463 |
| Rwanda | $6,171,801 |
| Namibia | $5,972,809 |
| Vietnam | $5,555,689 |
| Haiti | $5,035,000 |
| Zimbabwe | $4,265,000 |
| Thailand | $3,170,179 |
| Guyana | $3,069,571 |
| Malawi | $2,751,475 |
| India | $2,224,116 |
| Angola | $2,040,000 |
| Cambodia | $2,009,870 |
| Dominican Republic | $2,004,565 |
| South Sudan | $1,503,000 |
| Eswatini | $1,430,409 |
| Democratic Republic of the Congo | $1,378,317 |
| Lesotho | $835,000 |
| Ghana | $631,000 |
| Russia | $500,000 |
| China | $440,000 |
Organizational Types
| Own Agency | $238,736,571 |
Program Areas
| Management and Operations | $85,206,869 |
| Governance and Systems | $47,515,630 |
| Prevention | $14,902,017 |
| Care | $9,862,097 |
| Treatment | $9,360,397 |
| Testing | $3,280,835 |
Budget Codes
| HVMS: Management and Operations | $85,206,869 |
| HVSI: Strategic Information | $24,964,761 |
| HLAB: Laboratory Infrastructure | $15,658,162 |
| HTXS: Treatment: Adult Treatment | $8,837,150 |
| OHSS: Health Systems Strengthening | $6,892,707 |
| HVTB: Care: TB/HIV | $6,511,289 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,944,464 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,555,790 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,370,651 |
| HVCT: Testing: HIV Testing and Counseling | $3,280,835 |
| HBHC: Care: Adult Care and Support | $2,996,638 |
| HMBL: Biomedical Prevention: Blood Safety | $711,112 |
| HTXD: Treatment: ARV Drugs | $523,247 |
| HKID: Care: Orphans and Vulnerable Children | $354,170 |
| HMIN: Biomedical Prevention: Injection Safety | $320,000 |